Hence, EFE likely down-regulates the activation of the MAPK signaling pathway via selective inhibition of p38, ERK, and JNK by multiple compounds, which contributes to the anti-AD action of EFE. This evidence concerns the gene MAPK8 and Alzheimer disease.